IL6 and neurodegenerative disease: Significant increases in IFN-γ, IFN-α, TNF-α, and IL-6 responses, along with marked inhibition of OXPHOS responses, support the hypothesis that systemic chronic inflammation, exacerbated by metabolic conditions such as obesity, can contribute to the development and progression of neurodegenerative diseases.